3-Cyclohexylmethyl-2-(4-dimethylamino-phenyl)-3H-quinazolin-4-one

ID: ALA348567

PubChem CID: 44369278

Max Phase: Preclinical

Molecular Formula: C23H27N3O

Molecular Weight: 361.49

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc(-c2nc3ccccc3c(=O)n2CC2CCCCC2)cc1

Standard InChI:  InChI=1S/C23H27N3O/c1-25(2)19-14-12-18(13-15-19)22-24-21-11-7-6-10-20(21)23(27)26(22)16-17-8-4-3-5-9-17/h6-7,10-15,17H,3-5,8-9,16H2,1-2H3

Standard InChI Key:  SULCAFYSBWZKFE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    5.3792   -2.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3792   -3.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6625   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6667   -3.8125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9542   -2.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9542   -3.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0917   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1000   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6542   -1.3292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5167   -4.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292   -5.0500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0917   -4.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8125   -3.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8042   -5.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5167   -3.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0792   -1.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -3.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9500   -4.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292   -5.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8042   -0.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3750   -0.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5250   -2.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5250   -3.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3750   -0.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8042   -0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0875    0.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  3  1  0
  6  5  1  0
  7  1  1  0
  8  2  1  0
  9  3  2  0
 10 15  1  0
 11 10  1  0
 12  8  2  0
 13  8  1  0
 14 12  1  0
 15 13  2  0
 16  5  2  0
 17  7  1  0
 18  6  2  0
 19 11  1  0
 20 11  1  0
 21 17  1  0
 22 17  1  0
 23 16  1  0
 24 23  2  0
 25 22  1  0
 26 21  1  0
 27 25  1  0
  4  6  1  0
 14 10  2  0
 27 26  1  0
 24 18  1  0
M  END

Associated Targets(Human)

ABCC1 Tchem Multidrug resistance-associated protein 1 (2587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abcb1b P-glycoprotein 1 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.49Molecular Weight (Monoisotopic): 361.2154AlogP: 4.71#Rotatable Bonds: 4
Polar Surface Area: 38.13Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.88CX LogP: 5.07CX LogD: 5.07
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -1.11

References

1. Wang S, Ryder H, Pretswell I, Depledge P, Milton J, Hancox TC, Dale I, Dangerfield W, Charlton P, Faint R, Dodd R, Hassan S..  (2002)  Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.,  12  (4): [PMID:11844674] [10.1016/s0960-894x(01)00804-6]

Source